119-hres732

HRES
✓ Complete Data

Expressing support for the designation of September 30, 2025, as "Rare Cancer Day" to highlight the challenges patients with rare cancers face and to raise awareness and support efforts to improve early diagnosis and treatment.

Login to track bills
Introduced:
Sep 17, 2025
Policy Area:
Health

Bill Statistics

3
Actions
3
Cosponsors
0
Summaries
1
Subjects
1
Text Versions
Yes
Full Text

AI Summary

No AI Summary Available

Click the button above to generate an AI-powered summary of this bill using Claude.

The summary will analyze the bill's key provisions, impact, and implementation details.

Latest Action

Sep 17, 2025
Referred to the House Committee on Energy and Commerce.

Actions (3)

Referred to the House Committee on Energy and Commerce.
Type: IntroReferral | Source: House floor actions | Code: H11100
Sep 17, 2025
Submitted in House
Type: IntroReferral | Source: Library of Congress | Code: H11100
Sep 17, 2025
Submitted in House
Type: IntroReferral | Source: Library of Congress | Code: 1025
Sep 17, 2025

Subjects (1)

Health (Policy Area)

Text Versions (1)

Introduced in House

Sep 17, 2025

Full Bill Text

Length: 3,135 characters Version: Introduced in House Version Date: Sep 17, 2025 Last Updated: Nov 15, 2025 6:11 AM
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 732 Introduced in House

(IH) ]

<DOC>

119th CONGRESS
1st Session
H. RES. 732

Expressing support for the designation of September 30, 2025, as ``Rare
Cancer Day'' to highlight the challenges patients with rare cancers
face and to raise awareness and support efforts to improve early
diagnosis and treatment.

_______________________________________________________________________

IN THE HOUSE OF REPRESENTATIVES

September 17, 2025

Mr. Kelly of Pennsylvania (for himself, Ms. Wasserman Schultz, Mr.
Fitzpatrick, and Mrs. Dingell) submitted the following resolution;
which was referred to the Committee on Energy and Commerce

_______________________________________________________________________

RESOLUTION

Expressing support for the designation of September 30, 2025, as ``Rare
Cancer Day'' to highlight the challenges patients with rare cancers
face and to raise awareness and support efforts to improve early
diagnosis and treatment.

Whereas, approximately 1 in 5 people living with cancer in the United States is
diagnosed with a rare cancer;
Whereas all pediatric cancers are rare;
Whereas a quarter of all cancer deaths each year are due to rare cancers;
Whereas the 5-year survival rate is lower for patients with a rare cancer than
for those diagnosed with a more common cancer;
Whereas the early detection and treatment of rare cancers is challenging for
patients, providers, and scientists;
Whereas early detection of rare cancers currently is challenging for patients
because they are not aware of rare cancer symptoms;
Whereas the length of time that it takes for providers to diagnose a rare cancer
is longer than for more common cancers because symptoms may be unusual
and less recognizable;
Whereas efforts to increase awareness of rare cancer symptoms among patients and
clinicians would lead to earlier detection and improvements in survival
rates;
Whereas scientific understanding of and the development of effective treatments
for many rare cancers are less established than with more common
cancers; and
Whereas treatment options for many rare cancers currently are more limited than
with more common cancers: Now, therefore, be it
Resolved, That the House of Representatives--

(1) supports designating a ``Rare Cancer Day'';

(2) recognizes the challenges of detecting rare cancer;

(3) understands that rare cancer is prevalent among cancer
patients;

(4) acknowledges the devastating impact that rare cancer
has on individuals;

(5) recognizes the low survival rate of individuals with
rare cancer compared to more common cancers;

(6) supports increasing awareness of rare cancer symptoms
to increase early detection and improve survival rates;

(7) encourages partnerships with the medical and scientific
fields to improve the early diagnosis of rare cancers and to
develop effective treatments to eradicate them; and

(8) supports the dedication of funding to explore cures and
treatments for rare cancers.
<all>